{"transactions":[{"id":825188,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":2,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":3,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":4,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Voting Convertible Preferred Stock","published_at":"2026-03-31T01:16:12.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":335000,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to a Securities Purchase Agreement, dated March 26, 2026, by and among the Funds and HealthQuest Partners II L.P. (\"HealthQuest\"), HealthQuest sold to the Funds the shares of Common Stock and Voting Convertible Preferred Stock reported herein as sold by HealthQuest to the Funds for consideration in the form of promissory notes representing an aggregate principal balance payable by the Funds to HealthQuest of $755,646.90, allocated $754,159.42 to the Voting Convertible Stock sold thereunder and $1,487.48 to the Common Stock sold thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":1835000,"derivative":{"exercise_date":"2026-03-26","underlying":"Common Stock","underlying_shares":20301},"source":{"system":"sec-edgar","filing":"0001193125-26-132846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000119312526132846/ownership.xml","form_type":"4"}},{"id":825187,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":2,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":3,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":4,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Secured Subordinated Convertible Notes","published_at":"2026-03-31T01:16:12.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"reported_value":2611228.33,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The secured subordinated convertible notes (the \"Notes\") purchased by the Funds pursuant to the EW SPA have an aggregate principal balance of $2,611,228.33 (with accrued and unpaid interest as of March 25, 2026 of $82,862.98) and are convertible at any time into an aggregate of 189,756 shares of Common Stock at a conversion rate of 72.6691 shares of Common Stock for each $1,000.00 principal amount of Notes."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to a Securities Purchase Agreement (the \"EW SPA\"), dated March 26, 2026, by and among EW Healthcare Partners, L.P. (\"EWHP\"), EW Healthcare Partners-A, L.P. (\"EWHP-A\" and, together with EWHP, the \"EWHP Funds\"), Madryn Health Partners, LP (\"MHP\"), Madryn Health Partners (Cayman Master), LP (\"MHP Cayman\" and together with MHP, the \"Funds\"), and the other parties thereto, the EWHP Funds sold to the Funds the shares of Senior Convertible Preferred Stock, Voting Convertible Preferred Stock and Secured Subordinated Convertible Notes reported herein as sold by the EWHP Funds to the Funds for an aggregate sale price of $2,600,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The secured subordinated convertible notes (the \"Notes\") purchased by the Funds pursuant to the EW SPA have an aggregate principal balance of $2,611,228.33 (with accrued and unpaid interest as of March 25, 2026 of $82,862.98) and are convertible at any time into an aggregate of 189,756 shares of Common Stock at a conversion rate of 72.6691 shares of Common Stock for each $1,000.00 principal amount of Notes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The secured subordinated convertible notes (the \"Notes\") purchased by the Funds pursuant to the EW SPA have an aggregate principal balance of $2,611,228.33 (with accrued and unpaid interest as of March 25, 2026 of $82,862.98) and are convertible at any time into an aggregate of 189,756 shares of Common Stock at a conversion rate of 72.6691 shares of Common Stock for each $1,000.00 principal amount of Notes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"derivative":{"exercise_price":13.761,"exercise_date":"2026-03-26","expiration_date":"2026-12-09","underlying":"Common Stock","underlying_shares":189756},"source":{"system":"sec-edgar","filing":"0001193125-26-132846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000119312526132846/ownership.xml","form_type":"4"}},{"id":825186,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":2,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":3,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":4,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Senior Convertible Preferred Stock","published_at":"2026-03-31T01:16:12.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":1575810,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The shares of Senior Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.2424 shares of Common Stock for each share of Senior Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Senior Convertible Preferred Stock is perpetual and therefore has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to a Securities Purchase Agreement (the \"EW SPA\"), dated March 26, 2026, by and among EW Healthcare Partners, L.P. (\"EWHP\"), EW Healthcare Partners-A, L.P. (\"EWHP-A\" and, together with EWHP, the \"EWHP Funds\"), Madryn Health Partners, LP (\"MHP\"), Madryn Health Partners (Cayman Master), LP (\"MHP Cayman\" and together with MHP, the \"Funds\"), and the other parties thereto, the EWHP Funds sold to the Funds the shares of Senior Convertible Preferred Stock, Voting Convertible Preferred Stock and Secured Subordinated Convertible Notes reported herein as sold by the EWHP Funds to the Funds for an aggregate sale price of $2,600,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares of Senior Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.2424 shares of Common Stock for each share of Senior Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Senior Convertible Preferred Stock is perpetual and therefore has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The shares of Senior Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.2424 shares of Common Stock for each share of Senior Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Senior Convertible Preferred Stock is perpetual and therefore has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":1575810,"derivative":{"exercise_date":"2026-03-26","underlying":"Common Stock","underlying_shares":381976},"source":{"system":"sec-edgar","filing":"0001193125-26-132846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000119312526132846/ownership.xml","form_type":"4"}},{"id":825185,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":2,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":3,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":4,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Voting Convertible Preferred Stock","published_at":"2026-03-31T01:16:12.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":1500000,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to a Securities Purchase Agreement (the \"EW SPA\"), dated March 26, 2026, by and among EW Healthcare Partners, L.P. (\"EWHP\"), EW Healthcare Partners-A, L.P. (\"EWHP-A\" and, together with EWHP, the \"EWHP Funds\"), Madryn Health Partners, LP (\"MHP\"), Madryn Health Partners (Cayman Master), LP (\"MHP Cayman\" and together with MHP, the \"Funds\"), and the other parties thereto, the EWHP Funds sold to the Funds the shares of Senior Convertible Preferred Stock, Voting Convertible Preferred Stock and Secured Subordinated Convertible Notes reported herein as sold by the EWHP Funds to the Funds for an aggregate sale price of $2,600,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares of Voting Convertible Preferred Stock are convertible into shares of Common Stock at a ratio of 0.0606 shares of Common Stock for each share of Voting Convertible Preferred Stock at the option of the holder at any time or by the Issuer under certain conditions. The Voting Convertible Preferred Stock is perpetual and therefore has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":1500000,"derivative":{"exercise_date":"2026-03-26","underlying":"Common Stock","underlying_shares":90900},"source":{"system":"sec-edgar","filing":"0001193125-26-132846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000119312526132846/ownership.xml","form_type":"4"}},{"id":825184,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":2,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":3,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":4,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-31T01:16:12.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":37187,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to a Securities Purchase Agreement, dated March 26, 2026, by and among the Funds and HealthQuest Partners II L.P. (\"HealthQuest\"), HealthQuest sold to the Funds the shares of Common Stock and Voting Convertible Preferred Stock reported herein as sold by HealthQuest to the Funds for consideration in the form of promissory notes representing an aggregate principal balance payable by the Funds to HealthQuest of $755,646.90, allocated $754,159.42 to the Voting Convertible Stock sold thereunder and $1,487.48 to the Common Stock sold thereunder."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":37547373,"source":{"system":"sec-edgar","filing":"0001193125-26-132846","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000119312526132846/ownership.xml","form_type":"4"}},{"id":825183,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":2,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":3,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":4,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-31T01:16:12.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":37500000,"price":0.04,"value":1500000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a Stock Purchase Agreement, dated March 26, 2026, by and among Madryn Health Partners, LP (\"MHP\"), Madryn Health Partners (Cayman Master), LP (\"MHP Cayman\" and together with MHP, the \"Funds\"), and the Issuer, the Issuer sold to the Funds an aggregate of 37,500,000 shares of common stock for an aggregate purchase price of $1,500,000."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents securities held directly by MHP and MHP Cayman. Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":37510186,"source":{"system":"sec-edgar","filing":"0001193125-26-132846","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000119312526132846/ownership.xml","form_type":"4"}},{"id":1094801,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":2,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":3,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":4,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Y Convertible Preferred Stock","published_at":"2025-07-02T23:27:23.000Z","date":"2025-06-30","kind":"purchase","planned":false,"acquired":true,"shares":325651,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $17,015,808.30 (the \"Existing Notes\") for (i) new secured subordinated convertible notes in the aggregate principal amount of $11,096,478.80 (the \"New Notes\") and (ii) 325,651 shares of Series Y Convertible Preferred Stock (the \"Series Y Preferred Stock\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series Y Preferred Stock is perpetual and therefore has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Madryn Health Partners, LP (\"Health Partners LP\") and Madryn Health Partners (Cayman Master), LP (\"Cayman Master LP\" and together with Health Partners LP, the \"Funds\"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":1485531,"derivative":{"exercise_date":"2025-06-30","underlying":"Common Stock","underlying_shares":2960461},"source":{"system":"sec-edgar","filing":"0000950170-25-093416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000095017025093416/ownership.xml","form_type":"4"}},{"id":1094800,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":2,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":3,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":4,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Secured Subordinated Convertible Notes","published_at":"2025-07-02T23:27:23.000Z","date":"2025-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"reported_value":17015808.3,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $17,015,808.30 (the \"Existing Notes\") for (i) new secured subordinated convertible notes in the aggregate principal amount of $11,096,478.80 (the \"New Notes\") and (ii) 325,651 shares of Series Y Convertible Preferred Stock (the \"Series Y Preferred Stock\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Madryn Health Partners, LP (\"Health Partners LP\") and Madryn Health Partners (Cayman Master), LP (\"Cayman Master LP\" and together with Health Partners LP, the \"Funds\"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":264,"exercise_date":"2025-03-31","expiration_date":"2026-12-09","underlying":"Common Stock","underlying_shares":64454},"source":{"system":"sec-edgar","filing":"0000950170-25-093416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000095017025093416/ownership.xml","form_type":"4"}},{"id":1094799,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":2,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":3,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":4,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Secured Subordinated Convertible Notes","published_at":"2025-07-02T23:27:23.000Z","date":"2025-06-30","kind":"purchase","planned":false,"acquired":true,"reported_value":11096478.8,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The New Notes (as defined below) are convertible into shares of Common Stock at a conversion rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of New Notes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $17,015,808.30 (the \"Existing Notes\") for (i) new secured subordinated convertible notes in the aggregate principal amount of $11,096,478.80 (the \"New Notes\") and (ii) 325,651 shares of Series Y Convertible Preferred Stock (the \"Series Y Preferred Stock\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The New Notes (as defined below) are convertible into shares of Common Stock at a conversion rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of New Notes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Madryn Health Partners, LP (\"Health Partners LP\") and Madryn Health Partners (Cayman Master), LP (\"Cayman Master LP\" and together with Health Partners LP, the \"Funds\"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"derivative":{"exercise_price":264,"exercise_date":"2025-06-30","expiration_date":"2026-12-09","underlying":"Common Stock","underlying_shares":42032},"source":{"system":"sec-edgar","filing":"0000950170-25-093416","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000095017025093416/ownership.xml","form_type":"4"}},{"id":1183041,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":2,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":3,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":4,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Y Convertible Preferred Stock","published_at":"2025-04-02T21:47:31.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":379311,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The number of shares of Common Stock underlying the Series Y Preferred Stock gives effect to the Reverse Stock Split. Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $28,015,827.33 (the \"Existing Notes\") for (i) new secured subordinated convertible notes in the aggregate principal amount of $17,015,808.33 (the \"New Notes\") and (ii) 379,311 shares of Series Y Convertible Preferred Stock (the \"Series Y Preferred Stock\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series Y Preferred Stock is perpetual and therefore has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The number of shares of Common Stock underlying the Series Y Preferred Stock gives effect to the Reverse Stock Split. Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The number of shares of Common Stock underlying the Series Y Preferred Stock gives effect to the Reverse Stock Split. Each share of Series Y Preferred Stock is convertible into 9.0909 shares of Common Stock at the option of the holder or automatically upon certain conditions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Madryn Health Partners, LP (\"Health Partners LP\") and Madryn Health Partners (Cayman Master), LP (\"Cayman Master LP\" and together with Health Partners LP, the \"Funds\"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":1159880,"derivative":{"exercise_date":"2025-03-31","underlying":"Common Stock","underlying_shares":3448279},"source":{"system":"sec-edgar","filing":"0000950170-25-049649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000095017025049649/ownership.xml","form_type":"4"}},{"id":1183040,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":2,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":3,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":4,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Secured Subordinated Convertible Notes","published_at":"2025-04-02T21:47:31.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"reported_value":28015827.33,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Existing Notes were convertible at a rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of Existing Notes, after giving effect to a reverse stock split implemented by the Company on March 3, 2025 based on a one-for-eleven consolidation ratio (the \"Reverse Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $28,015,827.33 (the \"Existing Notes\") for (i) new secured subordinated convertible notes in the aggregate principal amount of $17,015,808.33 (the \"New Notes\") and (ii) 379,311 shares of Series Y Convertible Preferred Stock (the \"Series Y Preferred Stock\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The Existing Notes were convertible at a rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of Existing Notes, after giving effect to a reverse stock split implemented by the Company on March 3, 2025 based on a one-for-eleven consolidation ratio (the \"Reverse Stock Split\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Madryn Health Partners, LP (\"Health Partners LP\") and Madryn Health Partners (Cayman Master), LP (\"Cayman Master LP\" and together with Health Partners LP, the \"Funds\"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"derivative":{"exercise_price":264,"exercise_date":"2023-10-04","expiration_date":"2026-12-09","underlying":"Common Stock","underlying_shares":106121},"source":{"system":"sec-edgar","filing":"0000950170-25-049649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000095017025049649/ownership.xml","form_type":"4"}},{"id":1183039,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":2,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":3,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":4,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Secured Subordinated Convertible Notes","published_at":"2025-04-02T21:47:31.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"reported_value":17015808.33,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The New Notes (as defined below) are convertible into shares of Common Stock at a conversion rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of New Notes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $28,015,827.33 (the \"Existing Notes\") for (i) new secured subordinated convertible notes in the aggregate principal amount of $17,015,808.33 (the \"New Notes\") and (ii) 379,311 shares of Series Y Convertible Preferred Stock (the \"Series Y Preferred Stock\")."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The New Notes (as defined below) are convertible into shares of Common Stock at a conversion rate of 3.7878788 shares of Common Stock for each $1,000 principal amount of New Notes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Madryn Health Partners, LP (\"Health Partners LP\") and Madryn Health Partners (Cayman Master), LP (\"Cayman Master LP\" and together with Health Partners LP, the \"Funds\"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"derivative":{"exercise_price":264,"exercise_date":"2025-03-31","expiration_date":"2026-12-09","underlying":"Common Stock","underlying_shares":64454},"source":{"system":"sec-edgar","filing":"0000950170-25-049649","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000095017025049649/ownership.xml","form_type":"4"}},{"id":1397833,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":2,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":3,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":4,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Y Convertible Preferred Stock","published_at":"2024-10-01T00:20:08.000Z","date":"2024-09-26","kind":"purchase","planned":false,"acquired":true,"shares":203583,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Company's Series Y Convertible Preferred Stock (the \"Series Y Preferred Stock\") is convertible into one hundred (100) shares of Common Stock at any time at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transaction involved an exchange of $15,000,000 of existing senior secured indebtedness for 203,583 shares of Series Y Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series Y Preferred Stock is perpetual and therefore has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of the Company's Series Y Convertible Preferred Stock (the \"Series Y Preferred Stock\") is convertible into one hundred (100) shares of Common Stock at any time at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents securities held directly by Madryn Health Partners, LP (\"Health Partners LP\") and Madryn Health Partners (Cayman Master), LP (\"Cayman Master LP\" and together with Health Partners LP, the \"Funds\"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":780569,"derivative":{"exercise_date":"2024-09-26","underlying":"Common Stock","underlying_shares":20358300},"source":{"system":"sec-edgar","filing":"0000950170-24-110494","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000095017024110494/ownership.xml","form_type":"4"}},{"id":1499013,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":2,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":3,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":4,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Y Convertible Preferred Stock","published_at":"2024-05-29T22:58:48.000Z","date":"2024-05-24","kind":"purchase","planned":false,"acquired":true,"shares":576986,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Company's Series Y Convertible Preferred Stock (the \"Series Y Preferred Stock\") is convertible into one hundred (100) shares of Common Stock at any time at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported transaction involved an exchange of $35,000,000 of existing senior secured indebtedness for 576,986 shares of newly-created convertible preferred stock of the Company, designated as \"Series Y Convertible Preferred Stock\"."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series Y Preferred Stock is perpetual and therefore has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of the Company's Series Y Convertible Preferred Stock (the \"Series Y Preferred Stock\") is convertible into one hundred (100) shares of Common Stock at any time at the option of the holder or automatically upon certain conditions, including the completion by the Company of a $30.0 million common equity raise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents securities held directly by Madryn Health Partners, LP (\"Health Partners LP\") and Madryn Health Partners (Cayman Master), LP (\"Cayman Master LP\" and together with Health Partners LP, the \"Funds\"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":576986,"derivative":{"exercise_date":"2024-05-24","underlying":"Common Stock","underlying_shares":57698600},"source":{"system":"sec-edgar","filing":"0000950170-24-066139","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000095017024066139/ownership.xml","form_type":"4"}},{"id":1763416,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":2,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":3,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":4,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series X Convertible Preferred Stock","published_at":"2023-10-06T20:15:08.000Z","date":"2023-10-04","kind":"purchase","planned":false,"acquired":true,"shares":248755,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of Series X Convertible Preferred Stock is convertible into ten shares of Common Stock at any time at the option of the holder."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $26,695,110.58 (the \"Existing Notes\") for (i) new secured subordinated convertible notes in the aggregate principal amount of $22,791,748.32 (the \"New Notes\") and (ii) 248,755 shares of Series X Convertible Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series X Convertible Preferred Stock is perpetual and therefore has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Each share of Series X Convertible Preferred Stock is convertible into ten shares of Common Stock at any time at the option of the holder."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The Existing Notes were convertible at a rate of 20.5128205 shares of Common Stock for each $1,000 principal amount of Existing Notes, after giving effect to a reverse stock split implemented by the Company on May 11, 2023 based on a one-for-fifteen consolidation ratio."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Madryn Health Partners, LP (\"Health Partners LP\") and Madryn Health Partners (Cayman Master), LP (\"Cayman Master LP\" and together with Health Partners LP, the \"Funds\"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"balance_after":248755,"derivative":{"exercise_date":"2023-10-04","underlying":"Common Stock","underlying_shares":2487550},"source":{"system":"sec-edgar","filing":"0000950170-23-052401","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000095017023052401/ownership.xml","form_type":"4"}},{"id":1763415,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":2,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":3,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":4,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Secured Subordinated Convertible Notes","published_at":"2023-10-06T20:15:08.000Z","date":"2023-10-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"reported_value":26695110.58,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Existing Notes were convertible at a rate of 20.5128205 shares of Common Stock for each $1,000 principal amount of Existing Notes, after giving effect to a reverse stock split implemented by the Company on May 11, 2023 based on a one-for-fifteen consolidation ratio."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $26,695,110.58 (the \"Existing Notes\") for (i) new secured subordinated convertible notes in the aggregate principal amount of $22,791,748.32 (the \"New Notes\") and (ii) 248,755 shares of Series X Convertible Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Madryn Health Partners, LP (\"Health Partners LP\") and Madryn Health Partners (Cayman Master), LP (\"Cayman Master LP\" and together with Health Partners LP, the \"Funds\"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"derivative":{"exercise_price":48.75,"exercise_date":"2020-12-09","expiration_date":"2025-12-09","underlying":"Common Stock","underlying_shares":547593},"source":{"system":"sec-edgar","filing":"0000950170-23-052401","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000095017023052401/ownership.xml","form_type":"4"}},{"id":1763414,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":37188,"kind":"organization","name":"Madryn Asset Management, LP","position":1,"cik":"0001787423","reported_name":"Madryn Asset Management, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55307,"kind":"organization","name":"Madryn Health Partners, LP","position":2,"cik":"0001650490","reported_name":"Madryn Health Partners, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55305,"kind":"organization","name":"Madryn Health Partners (Cayman Master), LP","position":3,"cik":"0001836788","reported_name":"Madryn Health Partners (Cayman Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":55306,"kind":"organization","name":"Madryn Health Advisors, LP","position":4,"cik":"0001836559","reported_name":"Madryn Health Advisors, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Secured Subordinated Convertible Notes","published_at":"2023-10-06T20:15:08.000Z","date":"2023-10-04","kind":"purchase","planned":false,"acquired":true,"reported_value":22791748.32,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The New Notes (as defined below) are convertible at any time into shares of Common Stock at a conversion rate of 41.6666667 shares of Common Stock for each $1,000 principal amount of New Notes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $26,695,110.58 (the \"Existing Notes\") for (i) new secured subordinated convertible notes in the aggregate principal amount of $22,791,748.32 (the \"New Notes\") and (ii) 248,755 shares of Series X Convertible Preferred Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The New Notes (as defined below) are convertible at any time into shares of Common Stock at a conversion rate of 41.6666667 shares of Common Stock for each $1,000 principal amount of New Notes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by Madryn Health Partners, LP (\"Health Partners LP\") and Madryn Health Partners (Cayman Master), LP (\"Cayman Master LP\" and together with Health Partners LP, the \"Funds\"). Madryn Asset Management, LP, as investment advisor for each of the Funds, and Madryn Health Advisors, LP, as general partner of each of the Funds, may be deemed to be beneficial owners of the shares held directly by the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein."}],"derivative":{"exercise_price":24,"exercise_date":"2023-10-04","expiration_date":"2025-12-09","underlying":"Common Stock","underlying_shares":949657},"source":{"system":"sec-edgar","filing":"0000950170-23-052401","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000095017023052401/ownership.xml","form_type":"4"}}]}